Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001580642-24-006952
Filing Date
2024-11-14
Accepted
2024-11-14 12:19:37
Documents
2
Group Members
FINNY KURUVILLA, M.D. PH. D.ROBIN C. JOHN

Document Format Files

Seq Description Document Type Size
1 SC 13G/A eventide_inozyme-sc13g.htm SC 13G/A 53798
2 GRAPHIC image_001.gif GRAPHIC 97
  Complete submission text file 0001580642-24-006952.txt   55953
Mailing Address ONE INTERNATIONAL PLACE SUITE 4210 BOSTON MA 02110
Business Address ONE INTERNATIONAL PLACE SUITE 4210 BOSTON MA 02110 877-771-3836
EVENTIDE ASSET MANAGEMENT, LLC (Filed by) CIK: 0001442891 (see all company filings)

EIN.: 262508416 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210
Business Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210 857-330-4340
Inozyme Pharma, Inc. (Subject) CIK: 0001693011 (see all company filings)

EIN.: 475129768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91586 | Film No.: 241459295
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)